Does PARICALCITOL Cause Mobility decreased? 51 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 51 reports of Mobility decreased have been filed in association with PARICALCITOL (Paricalcitol). This represents 0.8% of all adverse event reports for PARICALCITOL.
51
Reports of Mobility decreased with PARICALCITOL
0.8%
of all PARICALCITOL reports
14
Deaths
35
Hospitalizations
How Dangerous Is Mobility decreased From PARICALCITOL?
Of the 51 reports, 14 (27.5%) resulted in death, 35 (68.6%) required hospitalization, and 3 (5.9%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PARICALCITOL. However, 51 reports have been filed with the FAERS database.
What Other Side Effects Does PARICALCITOL Cause?
Death (1,801)
Myocardial infarction (419)
Cardio-respiratory arrest (396)
Cardiac disorder (384)
Sepsis (277)
Infarction (233)
Cardiac failure (192)
Cerebrovascular accident (181)
Respiratory arrest (174)
General physical health deterioration (144)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which PARICALCITOL Alternatives Have Lower Mobility decreased Risk?
PARICALCITOL vs PARITAPREVIR
PARICALCITOL vs PAROXETINE
PARICALCITOL vs PAROXETINE\PAROXETINE
PARICALCITOL vs PAROXETINE\PAROXETINE ANHYDROUS
PARICALCITOL vs PASIREOTIDE